Imexpharm Company (IMP) recently announced business results for the first 5 months of revenue and profits 332 billion estimate 45.3 billion, 43.14% completion of the plan.
In which, in May, the company reached 71 billion in revenue and profit before tax of 8.7 billion.
2013, sales target IMP 850 billion and 105 billion profit. It is expected that the Company will take Penicillin injection plant in the industrial zone Vietnam - Singapore II Pacific operations this quarter. As planned, this year, the company will provide more market from 10-15 new products to expand distribution channels in Vung Tau and Ca Mau.
No comments:
Post a Comment